[1]
Nieto-Rios, J., Gómez de los Ríos, S., Serna-Higuita, L., Ocampo-Kohn, C., Aristizabal-Alzate, A., Gálvez-Cárdenas, K. and Zuluaga-Valencia, G. 2016. Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor. Colombia Médica. 47, 4 (Dec. 2016), 196-202. DOI:https://doi.org/10.25100/cm.v47i4.1989.